Literature DB >> 9284979

Group 5 determination in Pooideae grass pollen extracts by monoclonal antibody-based ELISA. Correlation with biologic activity.

J Ramírez1, T M Obispo, D Duffort, J A Carpizo, M J Chamorro, D Barber, H Ipsen, J Carreira, M Lombardero.   

Abstract

A solid-phase, monoclonal antibody-based ELISA was set up to quantitate group 5 allergens in pollen extracts of wild and cultivated Pooideae grasses. The method was able to evaluate group 5 concentration in mass units with a sensitivity in the ng/ml range and a practical working range of 1-100 ng/ml. The group 5 ELISA was compared with rocket immunoelectrophoresis for determination of allergen levels in several Phleum pratense extracts, and a very good quantitative correlation was found (r = 0.98; P < 0.0001). A highly significant correlation (r > 0.8) was also obtained in comparing allergenic potency determined by RAST inhibition to group 5 content in several wild and cultivated grass species. The results proved the usefulness of the method in the standardization of Pooideae pollen extracts employed in diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284979     DOI: 10.1111/j.1398-9995.1997.tb02151.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  3 in total

Review 1.  Evaluation of allergen vaccine potency.

Authors:  Robert E Esch
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

2.  Grass pollen production and group V allergen content of agriculturally relevant species and cultivars.

Authors:  Stephan Jung; Nicole Estrella; Michael W Pfaffl; Stephan Hartmann; Ellinor Handelshauser; Annette Menzel
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

3.  Allergenicity to worldwide invasive grass Cortaderia selloana as environmental risk to public health.

Authors:  Fernando Rodríguez; Manuel Lombardero-Vega; Lucía San Juan; Leticia de Las Vecillas; Sofía Alonso; Eva Morchón; Diego Liendo; Marta Uranga; Alberto Gandarillas
Journal:  Sci Rep       Date:  2021-12-24       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.